Alnylam Pharmaceuticals, Inc. (ALNY)
404.46
-10.75
(-2.59%)
USD |
NASDAQ |
Dec 10, 16:00
404.46
0.00 (0.00%)
After-Hours: 07:53
Alnylam Pharmaceuticals Total Assets (Quarterly): 4.852B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Glaukos Corp. | 999.38M |
| Bristol Myers Squibb Co. | 96.89B |
| BridgeBio Pharma, Inc. | 998.25M |
| Vertex Pharmaceuticals, Inc. | 24.86B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.618B |
| Shareholders Equity (Quarterly) | 233.89M |
| Debt to Equity Ratio | 11.86 |
| Current Ratio | 2.541 |
| Net Debt Paydown Yield | -0.02% |